Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of ASU 2016-13, net of tax effect
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Adoption of ASU 2016-13, net of tax effect
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Non-controlling interests
Adoption of ASU 2016-13, net of tax effect
Beginning Balance (in shares) at Dec. 31, 2019     66,338            
Beginning Balance at Dec. 31, 2019 $ 939,912 $ (14,105) $ 663 $ 1,102,303 $ (169,786) $ (14,031) $ 3,300 $ 3,432 $ (74)
Ending Balance (in shares) at Jun. 30, 2020     73,319            
Ending Balance at Jun. 30, 2020 1,067,964   $ 733 1,250,976 (198,719)   9,619 5,355  
Beginning Balance (in shares) at Dec. 31, 2019     66,338            
Beginning Balance at Dec. 31, 2019 939,912 $ (14,105) $ 663 1,102,303 (169,786) $ (14,031) 3,300 3,432 $ (74)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 57,746       57,491     255  
Unrealized gain (loss) on available-for-sale securities 12,280           12,222 58  
Unrealized gain (loss) on interest rate swaps (4,071)           (4,048) (23)  
Issued shares of common stock (in shares)     7,319            
Issued shares of common stock 188,798   $ 75 188,723          
Equity-based compensation 11,641     8,098       3,543  
Issuance (repurchase) of vested equity-based compensation shares (in shares)     537            
Issuance (repurchase) of vested equity-based compensation shares (17,288)   $ 5 (17,293)          
Other (in shares)     59            
Other 53     913       (860)  
Dividends and distributions (77,229)       (76,588)     (641)  
Ending Balance (in shares) at Sep. 30, 2020     74,253            
Ending Balance at Sep. 30, 2020 1,097,737   $ 743 1,282,744 (202,914)   11,474 5,690  
Beginning Balance (in shares) at Jun. 30, 2020     73,319            
Beginning Balance at Jun. 30, 2020 1,067,964   $ 733 1,250,976 (198,719)   9,619 5,355  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 21,277       21,175     102  
Unrealized gain (loss) on available-for-sale securities 872           864 8  
Unrealized gain (loss) on interest rate swaps 990           991 (1)  
Issued shares of common stock (in shares)     875            
Issued shares of common stock 29,248   $ 10 29,238          
Equity-based compensation 2,902     1,617       1,285  
Other (in shares)     59            
Other 54     913       (859)  
Dividends and distributions (25,570)       (25,370)     (200)  
Ending Balance (in shares) at Sep. 30, 2020     74,253            
Ending Balance at Sep. 30, 2020 1,097,737   $ 743 1,282,744 (202,914)   11,474 5,690  
Ending Balance (in shares) at Dec. 31, 2020     76,457            
Ending Balance at Dec. 31, 2020 1,210,149   $ 765 1,394,009 (204,112)   12,634 6,853  
Ending Balance (in shares) at Jun. 30, 2021     78,419            
Ending Balance at Jun. 30, 2021 1,322,547   $ 784 1,487,103 (193,530)   11,335 16,855  
Beginning Balance (in shares) at Dec. 31, 2020     76,457            
Beginning Balance at Dec. 31, 2020 1,210,149   $ 765 1,394,009 (204,112)   12,634 6,853  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 64,525       64,159     366  
Unrealized gain (loss) on available-for-sale securities (8,268)           (8,219) (49)  
Unrealized gain (loss) on interest rate swaps 3,351           3,331 20  
Issued shares of common stock (in shares)     2,496            
Issued shares of common stock 151,701   $ 25 151,676          
Equity-based compensation 17,965     5,226       12,739  
Conversion of convertible notes (in shares)     4,999            
Conversion of convertible notes 134,906   $ 50 134,856          
Issuance (repurchase) of vested equity-based compensation shares (in shares)     323            
Issuance (repurchase) of vested equity-based compensation shares (14,017)   $ 3 (14,020)          
Dividends and distributions (86,927)       (85,980)     (947)  
Ending Balance (in shares) at Sep. 30, 2021     84,275            
Ending Balance at Sep. 30, 2021 1,473,385   $ 843 1,671,747 (225,933)   7,746 18,982  
Beginning Balance (in shares) at Jun. 30, 2021     78,419            
Beginning Balance at Jun. 30, 2021 1,322,547   $ 784 1,487,103 (193,530)   11,335 16,855  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (3,099)       (2,838)     (261)  
Unrealized gain (loss) on available-for-sale securities (900)           (896) (4)  
Unrealized gain (loss) on interest rate swaps (2,703)           (2,693) (10)  
Issued shares of common stock (in shares)     857            
Issued shares of common stock 48,812   $ 9 48,803          
Equity-based compensation 3,715     985       2,730  
Conversion of convertible notes (in shares)     4,999            
Conversion of convertible notes 134,906   $ 50 134,856          
Dividends and distributions (29,893)       (29,565)     (328)  
Ending Balance (in shares) at Sep. 30, 2021     84,275            
Ending Balance at Sep. 30, 2021 $ 1,473,385   $ 843 $ 1,671,747 $ (225,933)   $ 7,746 $ 18,982